Successful cholecalciferol desensitisation in a case of delayed hypersensitivity
Asia Pacific Allergy
; (4): e14-2019.
Article
de En
| WPRIM
| ID: wpr-750179
Bibliothèque responsable:
WPRO
ABSTRACT
Hypersensitivity to cholecalciferol (vitamin D3) or its active metabolite, calcitriol, is an exceedingly rare clinical phenomenon, with only 2 previously reported cases of suspected immediate hypersensitivity. Diagnosis of delayed drug hypersensitivity reactions is inherently difficult due to the lack of any robust in vitro diagnostic assay, particularly in those patients for whom provocation testing confers an unacceptable risk. In these situations, diagnosis relies on reproducible clinical manifestations following administration of the culprit agent, resolution upon its withdrawal and exclusion of other potential differential diagnoses. Based on these criteria, we propose the first reported case of delayed hypersensitivity to cholecalciferol successfully managed with a desensitisation protocol to pure cholecalciferol.
Mots clés
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Techniques in vitro
/
Calcitriol
/
Cholécalciférol
/
Diagnostic
/
Diagnostic différentiel
/
Hypersensibilité médicamenteuse
/
Hypersensibilité
/
Hypersensibilité retardée
/
Hypersensibilité immédiate
Type d'étude:
Diagnostic_studies
/
Guideline
Limites du sujet:
Humans
langue:
En
Texte intégral:
Asia Pacific Allergy
Année:
2019
Type:
Article